Sensitive detection of Aβ protofibrils by proximity ligation - relevance for Alzheimer's disease

BMC Neuroscience

Volumn 11, Issue , 2010, Pages

  Kamali Moghaddam, Masood ^a   Pettersson, Frida E ^b   Wu, Di ^a   Englund, Hillevi ^b   Darmanis, Spyros ^a   Lord, Anna ^b   Tavoosidana, Gholamreza ^a   Sehlin, Dag ^b   Gustafsdottir, Sigrun ^a   Nilsson, Lars N G ^b   Lannfelt, Lars ^b   Landegren, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 158; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DNA; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; PEPTIDE FRAGMENT;

ALLELE; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASSAY; BRAIN HOMOGENATE; CONTROLLED STUDY; DNA STRAND; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN TARGETING; PROXIMITY LIGATION ASSAY; SENSITIVITY AND SPECIFICITY; SOLID; TRANSGENIC MOUSE; ANIMAL; CEREBROSPINAL FLUID; CHEMISTRY; GENETICS; HUMAN; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES, MONOCLONAL; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INDICATORS AND REAGENTS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION;

EID: 77957260419     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-11-124     Document Type: Article

References (20)

1. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006, 5(3):228-234. 10.1016/S1474-4422(06)70355-6, 16488378.
2. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 1999, 46(6):860-866. 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M, 10589538.
3. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 1999, 19(20):8876-8884.
4. Klyubin I, Walsh DM, Cullen WK, Fadeeva JV, Anwyl R, Selkoe DJ, Rowan MJ. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur J Neurosci 2004, 19(10):2839-2846. 10.1111/j.1460-9568.2004.03389.x, 15147317.
5. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007, 27(4):796-807. 10.1523/JNEUROSCI.3501-06.2007, 17251419.
6. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007, 27(11):2866-2875. 10.1523/JNEUROSCI.4970-06.2007, 17360908.
7. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416(6880):535-539. 10.1038/416535a, 11932745.
8. Johansson AS, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, Lannfelt L. Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt. FEBS J 2006, 273(12):2618-2630. 10.1111/j.1742-4658.2006.05263.x, 16817891.
9. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 2001, 4(9):887-893. 10.1038/nn0901-887, 11528419.
10. Englund H, Sehlin D, Johansson AS, Nilsson LN, Gellerfors P, Paulie S, Lannfelt L, Pettersson FE. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem 2007, 103(1):334-345.
11. Lord A, Englund H, Soderberg L, Tucker S, Clausen F, Hillered L, Gordon M, Morgan D, Lannfelt L, Pettersson FE, et al. Amyloid-beta protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice. FEBS J 2009, 276(4):995-1006. 10.1111/j.1742-4658.2008.06836.x, 2752010, 19215301.
12. Fredriksson S, Gullberg M, Jarvius J, Olsson C, Pietras K, Gustafsdottir SM, Ostman A, Landegren U. Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol 2002, 20(5):473-477. 10.1038/nbt0502-473, 11981560.
13. Gullberg M, Gustafsdottir SM, Schallmeiner E, Jarvius J, Bjarnegard M, Betsholtz C, Landegren U, Fredriksson S. Cytokine detection by antibody-based proximity ligation. Proc Natl Acad Sci USA 2004, 101(22):8420-8424. 10.1073/pnas.0400552101, 420409, 15155907.
14. Darmanis S, Nong RY, Hammond M, Gu J, Alderborn A, Vanelid J, Siegbahn A, Gustafsdottir S, Ericsson O, Landegren U, et al. Sensitive plasma protein analysis by microparticle-based proximity ligation assays. Mol Cell Proteomics 2010, 9(2):327-335. 10.1074/mcp.M900248-MCP200, 19955079.
15. Gustafsdottir SM, Nordengrahn A, Fredriksson S, Wallgren P, Rivera E, Schallmeiner E, Merza M, Landegren U. Detection of individual microbial pathogens by proximity ligation. Clin Chem 2006, 52(6):1152-1160. 10.1373/clinchem.2005.065847, 16723682.
16. Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, Nilsson LN. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Neurobiol Aging 2006, 27(1):67-77. 10.1016/j.neurobiolaging.2004.12.007, 16298242.
17. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA. Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci USA 2005, 102(7):2273-2276. 10.1073/pnas.0409336102, 548981, 15695586.
18. Englund H, Degerman Gunnarsson M, Brundin RM, Hedlund M, Kilander L, Lannfelt L, Pettersson FE. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid. Neurodegener Dis 2009, 6(4):139-147. 10.1159/000225376, 19521063.
19. Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M, Allsop D, Nakagawa M. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 24(8):2716-2726. 10.1096/fj.09-150359, 20339023.
20. Johansson AS, Garlind A, Berglind-Dehlin F, Karlsson G, Edwards K, Gellerfors P, Ekholm-Pettersson F, Palmblad J, Lannfelt L. Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro. FEBS J 2007, 274(4):990-1000. 10.1111/j.1742-4658.2007.05647.x, 17227385.